# Serotonin Simulation Enhancements for Scientific Use

This document outlines 100 proposed enhancements for the `/serotonin` page to transition it from a visual model to a scientifically viable simulation tool.

## I. Receptor Structural & Molecular Fidelity
1. **Atomic-Scale Resolution:** Implement 5-HT1A receptor models based on high-resolution Cryo-EM data (e.g., PDB: 7E2Y).
2. **Residue-Level Mapping:** Visualize the orthosteric binding pocket residues (e.g., Asp116, Ser199).
3. **7TM Helix Dynamics:** Accurate modeling of the seven-transmembrane alpha-helices with sequence-specific flexibility.
4. **Loop Modeling:** Inclusion of intracellular (ICL) and extracellular loops (ECL) with dynamic movement based on molecular dynamics (MD) simulations.
5. **C-Terminal Tail Visualization:** Representation of the disordered C-terminus and its phosphorylation sites.
6. **G-Protein Interface:** Modeling the Gαi/o coupling interface specifically for the 5-HT1A receptor.
7. **Isoform Support (5-HT2A):** Addition of the 5-HT2A receptor structure (PDB: 6WHA) with its distinct Gαq coupling mechanism.
8. **Ionotropic Representation (5-HT3):** Structural visualization of the pentameric 5-HT3 receptor (PDB: 4PIR).
9. **Gs-Coupled Variants:** Modeling of 5-HT4, 5-HT6, and 5-HT7 receptor architectures.
10. **Receptor Dimerization:** Visualizing homodimers and heterodimers (e.g., 5-HT2A-mGluR2 complexes).
11. **Allosteric Site Mapping:** Inclusion of known allosteric binding sites (e.g., zinc or sodium binding pockets).
12. **Palmitoylation Sites:** Modeling of C-terminal palmitoylation (e.g., Cys447 in 5-HT1A) and its effect on membrane anchoring.
13. **Glycosylation Modeling:** Representation of N-terminal glycosylation chains.
14. **Species Comparison:** Toggle between Human, Rodent, and Bovine receptor structures.
15. **Normal Mode Analysis (NMA):** Interactive visualization of the receptor's intrinsic vibrational modes.
16. **Solvent-Accessible Surface Area (SASA):** Heatmap overlays indicating SASA for the protein complex.
17. **Electrostatic Potential Mapping:** Visualization of the charge distribution across the receptor surface.
18. **Hydrophobicity Gradients:** Surface coloring based on the Kyte-Doolittle scale.
19. **Hydrogen Bond Networks:** Visualizing the internal water-mediated hydrogen bond networks within the GPCR core.
20. **Rotamer Toggle:** Ability to view different side-chain rotamer configurations for key pocket residues.

## II. Ligand & Pharmacological Interactions
21. **High-Fidelity Serotonin Model:** 3D representation of 5-Hydroxytryptamine with accurate bond lengths and charges.
22. **SSRI Modeling:** Visualizing the binding of Fluoxetine or Escitalopram to the Serotonin Transporter (SERT) (PDB: 5I6X).
23. **Triptan Binding:** Modeling of Sumatriptan interactions with 5-HT1B/1D receptors.
24. **Psychedelic Docking:** Representation of LSD or Psilocin in the 5-HT2A active state.
25. **Antipsychotic Profiles:** Visualization of Clozapine or Risperidone binding modes.
26. **5-HT3 Antagonists:** Modeling of Ondansetron binding within the pentameric channel.
27. **Partial Agonism Visualization:** Dynamic representation of Buspirone at the 5-HT1A receptor.
28. **Docking Trajectories:** Animated entry pathways of ligands into the orthosteric pocket.
29. **Affinity (Ki) Visualization:** Color-coding ligands based on their binding affinity.
30. **Residence Time Metrics:** Visual representation of ligand "off-rates" (koff).
31. **Conformational Switching:** Animation of the transition between inactive (GDP-bound) and active (GTP-bound) states.
32. **Biased Signaling Indicators:** Visual feedback on G-protein vs. Beta-arrestin recruitment bias.
33. **Competitive Displacement:** Interactive simulation of an antagonist displacing an agonist.
34. **ECL2 "Lid" Dynamics:** Modeling the closure of the extracellular loop 2 over the ligand.
35. **Structural Water molecules:** Inclusion of conserved water molecules critical for ligand binding.
36. **EC50/IC50 Overlays:** Integrating dose-response curves into the 3D viewport.
37. **Schild Plot Integration:** For analyzing competitive antagonism in real-time.
38. **Hill Coefficient Feedback:** Representing cooperativity in multi-binding site simulations.
39. **Prodrug Conversion:** Visualizing the metabolism of Psilocybin to Psilocin prior to binding.
40. **Pharmacophore Mapping:** Overlaying pharmacophore requirements (H-bond donors/acceptors) onto the pocket.

## III. Membrane & Cellular Environment
41. **Realistic Lipid Bilayer:** Multi-component membrane simulation (PC, PE, PS).
42. **Cholesterol Modulation:** Visualizing how cholesterol concentration affects 5-HT1A stability.
43. **Lipid Raft Partitioning:** Representation of receptor clustering in liquid-ordered domains.
44. **Synaptic Cleft Scale:** Modeling the 20nm synaptic gap with appropriate volume constraints.
45. **SERT Inclusion:** Adding the Serotonin Transporter to the presynaptic membrane visualization.
46. **VMAT2 Loading:** Modeling vesicular monoamine transporter 2 on synaptic vesicles.
47. **Exocytosis Animation:** Vesicle docking, priming, and fusion sequence.
48. **Extracellular Matrix (ECM):** Representation of chondroitin sulfate proteoglycans in the cleft.
49. **Cytoskeletal Anchoring:** Visualizing Actin/Tubulin interactions with the C-terminus.
50. **Internalization Pathways:** Modeling clathrin-mediated endocytosis of receptors.
51. **Recycling Endosomes:** Path of receptor resensitization and return to the membrane.
52. **Lysosomal Degradation:** Visualizing receptor turnover.
53. **Ion Gradients:** Dynamic display of Na+, K+, and Ca2+ concentrations.
54. **Membrane Potential (Vm):** Real-time display of the voltage across the simulated membrane.
55. **Glycocalyx Representation:** Including the carbohydrate coat on the extracellular surface.
56. **Crowding Effects:** Adding non-functional proteins to simulate a dense cellular environment.
57. **Diffusion Coefficients:** Adjusting ligand movement based on synaptic vs. extrasynaptic viscosity.
58. **Volume Transmission:** Visualizing serotonin diffusion away from the synapse.
59. **Astrocytic Uptake:** Modeling the role of glial cells in clearing serotonin.
60. **BBB Transport:** Visualizing the transport of L-Tryptophan via LAT1 transporters.

## IV. Biochemical Pathways & Metabolism
61. **TPH2 Enzyme Kinetics:** Visualizing the rate-limiting step of serotonin synthesis.
62. **AADC Conversion:** Modeling the decarboxylation of 5-HTP.
63. **MAO-A Degradation:** Representing the oxidative deamination of serotonin.
64. **5-HIAA Production:** Visualizing the final metabolic product of serotonin.
65. **Melatonin Pathway:** Branching pathway showing serotonin conversion to melatonin in the pineal gland.
66. **ATP Dependency:** Visualizing the energy requirements for vesicular loading.
67. **Cofactor Requirement:** Representation of BH4 and Iron as TPH cofactors.
68. **Feedback Inhibition:** Modeling how high 5-HT levels suppress TPH activity.
69. **Vitamin B6 Role:** AADC dependence on Pyridoxal-5-phosphate.
70. **TPH1 vs TPH2:** Differentiating between peripheral and central serotonin synthesis.
71. **Depletion Simulation:** Visualizing the effect of p-Chlorophenylalanine (PCPA).
72. **Serotonin Syndrome Model:** Simulating toxic accumulation levels.
73. **Metabolic Flux Analysis:** Real-time graph of synthesis vs. degradation rates.
74. **KEGG Map Integration:** Interactive link to Map00380 (Tryptophan metabolism).
75. **Tryptophan Competition:** Visualizing the LNAA ratio at the Blood-Brain Barrier.
76. **Gut-Brain Axis:** Including the contribution of enterochromaffin cells (TPH1).
77. **Kynurenine Shunt:** Visualizing the competing pathway for Tryptophan.
78. **IDO Induction:** Modeling how inflammation shunts Tryptophan away from Serotonin.
79. **Serotonylation:** Representation of serotonin covalent binding to proteins (e.g., Rac1).
80. **Turnover Metrics:** Displaying the 5-HT / 5-HIAA ratio.

## V. Signal Transduction & Dynamics
81. **G-Protein Cycle:** Visualizing GDP to GTP exchange on Gαi/o.
82. **Subunit Dissociation:** Separation of Gα from Gβγ.
83. **Adenylyl Cyclase Inhibition:** Modeling the reduction of cAMP production.
84. **cAMP Concentration Heatmap:** Dynamic visualization of second messenger levels.
85. **PKA Activity Modulation:** Visualizing the downstream effect of lowered cAMP.
86. **GIRK Channel Activation:** Gβγ-mediated opening of potassium channels.
87. **Calcium Channel Inhibition:** G-protein mediated suppression of N-type Ca2+ channels.
88. **PLC Pathway (5-HT2):** Activation of Phospholipase C and IP3/DAG production.
89. **ER Calcium Release:** IP3-triggered calcium release from internal stores.
90. **PKC/CaMKII Activation:** Downstream kinase cascades visualization.
91. **MAPK/ERK Signaling:** Long-term signaling effects on gene expression.
92. **CREB Phosphorylation:** Nuclear translocation of signals to affect transcription.
93. **Beta-Arrestin Scaffolding:** Modeling the recruitment of Arrestin-2/3.
94. **GRK Phosphorylation:** Visualization of G-protein coupled receptor kinases.
95. **Desensitization Kinetics:** Time-course of receptor responsiveness loss.
96. **Heterologous Desensitization:** Cross-talk inhibition from other GPCRs.
97. **D2-5HT2A Crosstalk:** Visualizing the interaction between dopamine and serotonin signaling.
98. **BDNF Induction:** Modeling the link between serotonin and neurotrophic factors.
99. **Electrophysiological Traces:** Overlays of simulated neuronal firing rates.
100. **Exportable Parameters:** Ability to export simulation state as JSON/CSV for external analysis.
